Literature DB >> 29259416

A case of primary ciliary dyskinesia treated with ICSI using testicular spermatozoa: case report and a review of the literature.

Akiko Kawasaki1,2, Hajime Okamoto2, Atsushi Wada2, Yoko Ainoya2, Naoki Kita2, Tetsuro Maeyama2, Naoko Edamoto2, Hiroyuki Nishiyama3, Sadamu Tsukamoto4, Akira Joraku3, Natsui Waku4, Hiroyuki Yoshikawa1.   

Abstract

Purpose: To investigate whether or not intracytoplasmic sperm injection (ICSI) using spermatozoa extracted from testis (TESE-ICSI) is a more effective treatment than ICSI with ejaculated spermatozoa (EJ-ICSI) for primary ciliary dyskinesia (PCD).
Methods: We reported a case of PCD in which we performed TESE-ICSI after repeated failure of EJ-ICSI. Together with data from previous case reports, we compared the fertilization rate and pregnancy outcome of TESE-ICSI and EJ-ICSI.
Results: In our case, TESE-ICSI improved the morphology of spermatozoa and fertilization rate. However, the outcome was only a biochemical pregnancy. According to the analysis combined with previous reports, there was no difference in the fertilization rate and pregnancy outcome parameters between TESE-ICSI and EJ-ICSI. Conclusions: TESE-ICSI for PCD may improve the fertilization rate compared to EJ-ICSI. However, it does not necessarily improve the pregnancy outcome for a patient with primary ciliary dyskinesia.

Entities:  

Keywords:  HOS test; ICSI; Kartagener's syndrome; Primary ciliary dyskinesia; TESE

Year:  2015        PMID: 29259416      PMCID: PMC5715828          DOI: 10.1007/s12522-015-0210-z

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  21 in total

1.  Different fertilization rates between immotile testicular spermatozoa and immotile ejaculated spermatozoa for ICSI in men with Kartagener's syndrome: case reports.

Authors:  G Westlander; M Barry; O Petrucco; R Norman
Journal:  Hum Reprod       Date:  2003-06       Impact factor: 6.918

2.  Birth of healthy twins after intracytoplasmic sperm injection using ejaculated immotile spermatozoa from a patient with Kartagener's syndrome.

Authors:  S Geber; M Lemgruber; P F Taitson; M Valle; M Sampaio
Journal:  Andrologia       Date:  2011-09-26       Impact factor: 2.775

3.  Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa.

Authors:  Ermanno Greco; Filomena Scarselli; Marcello Iacobelli; Laura Rienzi; Filippo Ubaldi; Susanna Ferrero; Giorgio Franco; Nazareno Anniballo; Carmen Mendoza; Jan Tesarik
Journal:  Hum Reprod       Date:  2004-11-11       Impact factor: 6.918

4.  Therapeutic approach of immotile cilia syndrome by intracytoplasmic sperm injection: a case report.

Authors:  J Papadimas; B C Tarlatzis; H Bili; T Sotiriadis; K Koliakou; J Bontis; S Mantalenakis
Journal:  Fertil Steril       Date:  1997-03       Impact factor: 7.329

5.  Failure of fertilization after intracytoplasmic sperm injection in a patient with Kartagener's syndrome and totally immotile spermatozoa: case report.

Authors:  A Abu-Musa; A Hannoun; A Khabbaz; P Devroey
Journal:  Hum Reprod       Date:  1999-10       Impact factor: 6.918

Review 6.  Pregnancy after ICSI with ejaculated immotile spermatozoa from a patient with immotile cilia syndrome: a case report and review of the literature.

Authors:  Karen Peeraer; Martine Nijs; Dominique Raick; Willem Ombelet
Journal:  Reprod Biomed Online       Date:  2004-12       Impact factor: 3.828

7.  Decline in fertility of mouse sperm with abnormal chromatin during epididymal passage as revealed by ICSI.

Authors:  Ryota Suganuma; Ryuzo Yanagimachi; Marvin L Meistrich
Journal:  Hum Reprod       Date:  2005-07-21       Impact factor: 6.918

8.  DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm.

Authors:  Niki Tomas Loges; Heike Olbrich; Lale Fenske; Huda Mussaffi; Judit Horvath; Manfred Fliegauf; Heiner Kuhl; Gyorgy Baktai; Erzsebet Peterffy; Rahul Chodhari; Eddie M K Chung; Andrew Rutman; Christopher O'Callaghan; Hannah Blau; Laszlo Tiszlavicz; Katarzyna Voelkel; Michal Witt; Ewa Zietkiewicz; Juergen Neesen; Richard Reinhardt; Hannah M Mitchison; Heymut Omran
Journal:  Am J Hum Genet       Date:  2008-10-23       Impact factor: 11.025

9.  Successful twin birth following blastocyst culture of embryos derived from the immotile ejaculated spermatozoa from a patient with primary ciliary dyskinesia: a case report.

Authors:  Richard J Kordus; Robert L Price; Jeffrey M Davis; Gail F Whitman-Elia
Journal:  J Assist Reprod Genet       Date:  2008-10-15       Impact factor: 3.412

10.  Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children.

Authors:  A Barbato; T Frischer; C E Kuehni; D Snijders; I Azevedo; G Baktai; L Bartoloni; E Eber; A Escribano; E Haarman; B Hesselmar; C Hogg; M Jorissen; J Lucas; K G Nielsen; C O'Callaghan; H Omran; P Pohunek; M-P F Strippoli; A Bush
Journal:  Eur Respir J       Date:  2009-12       Impact factor: 16.671

View more
  3 in total

1.  Patients with severe asthenoteratospermia carrying SPAG6 or RSPH3 mutations have a positive pregnancy outcome following intracytoplasmic sperm injection.

Authors:  Huan Wu; Jiajia Wang; Huiru Cheng; Yang Gao; Wangjie Liu; Zhiguo Zhang; Huanhuan Jiang; Weiyu Li; Fuxi Zhu; Mingrong Lv; Chunyu Liu; Qing Tan; Xiaofeng Zhang; Chao Wang; Xiaoqing Ni; Yujie Chen; Bing Song; Ping Zhou; Zhaolian Wei; Feng Zhang; Xiaojin He; Yunxia Cao
Journal:  J Assist Reprod Genet       Date:  2020-03-02       Impact factor: 3.412

2.  Novel DNAAF6 variants identified by whole-exome sequencing cause male infertility and primary ciliary dyskinesia.

Authors:  Ying Wang; Chaofeng Tu; Hongchuan Nie; Lanlan Meng; Dongyan Li; Weili Wang; Huan Zhang; Guangxiu Lu; Ge Lin; Yue-Qiu Tan; Juan Du
Journal:  J Assist Reprod Genet       Date:  2020-03-13       Impact factor: 3.412

Review 3.  Sperm defects in primary ciliary dyskinesia and related causes of male infertility.

Authors:  Anu Sironen; Amelia Shoemark; Mitali Patel; Michael R Loebinger; Hannah M Mitchison
Journal:  Cell Mol Life Sci       Date:  2019-11-28       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.